India's tally of cases of the coronavirus disease (Covid-19) stood crossed nine million after 45,882 new infections were recorded between Thursday and Friay. This spike, which took India's tally to 9,004,365, comes amid a surge of infection in several states, including Delhi. On Thursday, Delhi CM Arvind Kejriwal chaired an all-party meet and announced several measures, including ₹2,000 fine for those not wearing masks in public places.
Click here for full Covid-19 coverage
Meanwhile, in Gujarat, the state government announced a 'complete curfew' in Ahmedabad from 9pm on November 20 to 6am on November 21 to control the surge in cases there. Also, the government said, schools and colleges, which were scheduled to reopen from November 23, won't reopen from the said date due to the Covid-19 situation in the state.
US officials worry about holiday spike as coronavirus surges
US health authorities braced for further increases in coronvirus cases, hospitalizations and deaths on Friday, capping a week in which the spread of the novel coronavirus accelerated ahead of next week's Thanksgiving holiday, reports Reuters.
UK asks regulator to assess Pfizer vaccine for suitability
Britain has formally asked its medical regulator, the MHRA, to assess the vaccine being produced by Pfizer Inc and its German partner BioNTech , health minister Matt Hancock said on Friday, reports Reuters.
Higher positivity rate of Covid-19 in Noida's random testing at Delhi borders
The positivity rate among people randomly tested for Covid-19 at Gautam Buddh Nagar's Delhi border was higher than in non-border areas of the district on Thursday, according to officials, reports PTI.
Delhi records 6,608 new Covid-19 cases and 118 deaths
Delhi records 6,608 new Covid-19 cases and 118 deaths in last 24 hours, taking total tally to 5,17,238. 62,425 tests were conducted and the Covid positivity rate in the capital stands at 10.59%, as per official health bulletin.
WHO suspends remdesivir from Covid-19 list of medicines
The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients, reports Reuters.
Night curfew to be imposed in 5 districts of Madhya Pradesh, starting Nov 21: CM Chouhan
First published: Nov 20, 2020 07:00 IST